SCHEMBL662256

SCHEMBL662256

Brc1c[c]c2ccccc2c1Br

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10839663 0.78 CYP2A6 (0.37)
SCHEMBL11635282 0.74 L3MBTL1 (0.38)
SCHEMBL578709 0.72 CYP2A6 (0.32)
SCHEMBL7432627 0.71 PARP1 (0.34)
SCHEMBL4311977 0.71
SCHEMBL629844 0.70 CYP1A2 (0.31)
SCHEMBL6152174 0.70 CYP1A2 (0.31)
SCHEMBL25131 0.67 ALDH1A1 (0.46)
SCHEMBL17200851 0.67 ALDH1A1 (0.33)
SCHEMBL535426 0.65 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104203884-B Passivation of homogeneous hydrogenation catalysts for the production of ethylene glycol 伊士曼化工公司 2017-04-05 CN disclosed
CN-103153463-B The method of recovery and recycle of ruthenium homogeneous catalyst EASTMAN CHEMICAL CO. (US) 2015-09-09 CN disclosed
US-8969632-B2 Passivation of a homogeneous hydrogenation catalyst for the production of ethylene glycol EASTMAN CHEMICAL COMPANY (US) 2015-03-03 US disclosed
EP-2828229-A1 PASSIVATION OF A HOMEGENEOUS HYDROGENATION CATALYST FOR THE PRODUCTION OF ETHYLENE GLYCOL Eastman Chemical Company (US) 2015-01-28 EP disclosed
US-8829248-B2 Method for recovery and recycle of ruthenium homogeneous catalysts EASTMAN CHEMICAL COMPANY (US) 2014-09-09 US disclosed
CN-101878188-B Hydrogenation process for the preparation of 1, 2-diols EASTMAN CHEM CO 2014-07-23 CN disclosed
US-8779214-B2 Methods for recovery and recycle of ruthenium homogenous catalysts EASTMAN CHEMICAL COMPANY (US) 2014-07-15 US disclosed
WO-2013142091-A1 PASSIVATION OF A HOMEGENEOUS HYDROGENATION CATALYST FOR THE PRODUCTION OF ETHYLENE GLYCOL EASTMAN CHEMICAL COMPANY (US) 2013-09-26 WO disclosed
US-20130253232-A1 METHODS FOR RECOVERY AND RECYCLE OF RUTHENIUM HOMOGENOUS CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2013-09-26 US disclosed
US-20130253230-A1 PASSIVATION OF A HOMOGENEOUS HYDROGENATION CATALYST FOR THE PRODUCTION OF ETHYLENE GLYCOL EASTMAN CHEMICAL COMPANY (US) 2013-09-26 US disclosed
EP-0923734-A1 QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES Trega Biosciences, Inc. (US) 1999-06-23 EP disclosed
US-5874443-A BIOSYNTHESIS TREGA BIOSCIENCES, INC. (US) 1999-02-23 US disclosed
CN-1202888-A Isoquinoline derivatives and isoquinoline combinatorial libraries TORREY PINES INST (US) 1998-12-23 CN disclosed
US-5840500-A OPIOD RECEPTORS AS ANALGESICS AND CENTRALLY ACTING PAIN KILLERS TREGA BIOSCIENCES, INC. (US) 1998-11-24 US disclosed
EP-0863877-A1 ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 1998-09-16 EP disclosed
WO-1998034115-A1 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 1998-08-06 WO disclosed
WO-1998034111-A1 TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 1998-08-06 WO disclosed
WO-1998002741-A9 QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES 1998-05-22 WO disclosed
WO-1998002741-A1 QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 1998-01-22 WO disclosed
WO-1997016428-A1 ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 1997-05-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130253232-A1 METHODS FOR RECOVERY AND RECYCLE OF RUTHENIUM HOMOGENOUS CATALYSTS DERA, GRHPR, APEH POLB 1053/4885
US-20130253230-A1 PASSIVATION OF A HOMOGENEOUS HYDROGENATION CATALYST FOR THE PRODUCTION OF ETHYLENE GLYCOL HPD, TALDO1, GRHPR POLB 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.